Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection
DF Bavaro(University of Bari Aldo Moro), Annalisa Saracino(University of Bari Aldo Moro), Onofrio Resta(Association for Symbolic Logic), Enrico Buonamico(University of Bari Aldo Moro), Lucia Diella(Humanitas University), Maricla Marrone(University of Bari Aldo Moro), Antonio Giovanni Solimando(University of Parma), F Carpagnano, M Ciannarella(University of Bari Aldo Moro), Alessandro Dell’Erba(University of Bari Aldo Moro), Maurizio Aricò(University of Bari Aldo Moro), Cristina Stasi, V. M. Palmieri(University of Bari Aldo Moro), Maria Dell’Aera(Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari), G Migliore, Angelo Vacca(University of Bari Aldo Moro), GE Carpagnano(University of Bari Aldo Moro), Sebastiano Cicco
Cited by 10
Related Papers
Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2000|599
A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation
|European Respiratory Journal|2005|383
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264
Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group
|Blood|2013|248
Clinical Outcome of Children With Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Treated Between 1995 and 2005
|Journal of Clinical Oncology|2010|247